|Articles|May 1, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
20 Years of Survivorship After Acute Myeloid Leukemia
2
Gynecologic Cancer Awareness Month: What Every Woman Should Ask Her Doctor
3
FDA Approves Zenbexus Combination for Patients With Multiple Myeloma After Prior Treatment
4
I Need to Manage My Fatigue While Living With Cancer
5